{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T03:30:11Z","timestamp":1779939011708,"version":"3.53.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-C01-110018"],"award-info":[{"award-number":["TSGH-C01-110018"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annalsthoracicsurgery.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Annals of Thoracic Surgery"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.athoracsur.2021.09.048","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T06:48:17Z","timestamp":1635317297000},"page":"1951-1964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparing Single- and Dual-Antiplatelet Therapies After Transcatheter Aortic Valve Implantation"],"prefix":"10.1016","volume":"114","author":[{"given":"Hao-Tse","family":"Chiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Jie","family":"Jhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Huang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cho-Hao","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.athoracsur.2021.09.048_bib1","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","article-title":"Transcatheter versus surgical aortic-valve replacement in high-risk patients","volume":"364","author":"Smith","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib2","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib3","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients","volume":"380","author":"Popma","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib4","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/956252","article-title":"A\u00a0review of most relevant complications of transcatheter aortic valve implantation","volume":"2013","author":"Neragi-Miandoab","year":"2013","journal-title":"ISRN Cardiol"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib6","first-page":"e35","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College Of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib7","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib8","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1161\/CIRCULATIONAHA.106.639450","article-title":"Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study","volume":"114","author":"Grube","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib9","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jacc.2014.12.046","article-title":"Short-versus long-term dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysis","volume":"65","author":"Palmerini","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib11","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib13","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib14","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.athoracsur.2020.05.187","article-title":"Systematic reviews and meta-analyses in cardiac surgery: rules of the road-part 2","volume":"111","author":"Gaudino","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib15","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.athoracsur.2020.05.148","article-title":"Systematic reviews and meta-analyses in cardiac surgery: rules of the road-part 1","volume":"111","author":"Gaudino","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib16","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1093\/eurheartj\/ehs255","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document","volume":"33","author":"Kappetein","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib17","first-page":"ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib18","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1002\/sim.1009","article-title":"A\u00a0refined method for the meta-analysis of controlled clinical trials with binary outcome","volume":"20","author":"Hartung","year":"2001","journal-title":"Stat Med"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib19","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/sim.7223","article-title":"Combining randomized and non-randomized evidence in network meta-analysis","volume":"36","author":"Efthimiou","year":"2017","journal-title":"Stat Med"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jrsm.13","article-title":"Critical interpretation of Cochran\u2019s Q test depends on power and prior assumptions about heterogeneity","volume":"1","author":"Pereira","year":"2010","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/sim.1040","article-title":"Advanced methods in meta-analysis: multivariate approach and meta-regression","volume":"21","author":"van Houwelingen","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib23","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/biom.12817","article-title":"Quantifying publication bias in meta-analysis","volume":"74","author":"Lin","year":"2018","journal-title":"Biometrics"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib24","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","article-title":"Trial sequential analysis in systematic reviews with meta-analysis","volume":"17","author":"Wetterslev","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/anae.14705","article-title":"Trial sequential analysis: adding a new dimension to meta-analysis","volume":"75","author":"Shah","year":"2020","journal-title":"Anaesthesia"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib27","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/sim.4780131308","article-title":"Interim analysis: the alpha spending function approach","volume":"13","author":"DeMets","year":"1994","journal-title":"Stat Med"},{"issue":"suppl_2","key":"10.1016\/j.athoracsur.2021.09.048_bib28","doi-asserted-by":"crossref","first-page":"ii23","DOI":"10.1093\/ndt\/gfw219","article-title":"When is a meta-analysis conclusive? A guide to trial sequential analysis with an example of remote ischemic preconditioning for renoprotection in patients undergoing cardiac surgery","volume":"32","author":"Roshanov","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/1536867X1301300106","article-title":"Trial sequential boundaries for cumulative meta-analyses","volume":"13","author":"Miladinovic","year":"2013","journal-title":"Stata J"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib30","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.amjcard.2011.07.049","article-title":"Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation","volume":"108","author":"Ussia","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib31","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ijcard.2014.04.170","article-title":"SAT-TAVI (single antiplatelet therapy for TAVI) study: a pilot randomized study comparing double to single antiplatelet therapy for transcatheter aortic valve implantation","volume":"174","author":"Stabile","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib32","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jcin.2017.04.014","volume":"10","author":"Rodes-Cabau","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib33","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJMoa2017815","article-title":"Aspirin with or without clopidogrel after transcatheter aortic-valve implantation","volume":"383","author":"Brouwer","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib34","first-page":"544","article-title":"Antiplatelet and antithrombotic treatment after transcatheter aortic valve implantation \u2013 comparison of regimes","volume":"25","author":"Poliacikova","year":"2013","journal-title":"J\u00a0Invasive Cardiol"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib35","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.amjcard.2013.09.033","article-title":"Comparison of two antiplatelet therapy strategies in patients undergoing transcatheter aortic valve implantation","volume":"113","author":"Durand","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib36","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1253\/circj.CJ-16-0903","article-title":"Clinical outcomes and bioprosthetic valve function after transcatheter aortic valve implantation under dual antiplatelet therapy vs. aspirin alone","volume":"81","author":"Ichibori","year":"2017","journal-title":"Circ J"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib37","doi-asserted-by":"crossref","first-page":"e1392","DOI":"10.4244\/EIJ-D-17-00198","article-title":"Which is the best antiaggregant or anticoagulant therapy after TAVI? A propensity-matched analysis from the ITER registry. The management of DAPT after TAVI","volume":"13","author":"D\u2019Ascenzo","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ahj.2018.06.006","article-title":"Variation in post-TAVR antiplatelet therapy utilization and associated outcomes: insights from the STS\/ACC TVT registry","volume":"204","author":"Sherwood","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/jrsm.1266","article-title":"Detecting small-study effects and funnel plot asymmetry in meta-analysis of survival data: a comparison of new and existing tests","volume":"9","author":"Debray","year":"2018","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrcardio.2017.116","article-title":"Future of transcatheter aortic valve implantation-evolving clinical indications","volume":"15","author":"Puri","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib41","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jacc.2012.01.001","article-title":"2012 ACCF\/AATS\/SCAI\/STS expert consensus document on transcatheter aortic valve replacement","volume":"59","author":"Holmes","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib42","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.jacc.2012.02.022","article-title":"Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies","volume":"59","author":"G\u00e9n\u00e9reux","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib43","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.001779","article-title":"Treatment and clinical outcomes of transcatheter heart valve thrombosis","volume":"8","author":"Latib","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib44","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/j.jacc.2014.08.052","article-title":"Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement","volume":"64","author":"G\u00e9n\u00e9reux","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib45","doi-asserted-by":"crossref","first-page":"e1159","DOI":"10.1161\/CIR.0000000000000503","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Nishimura","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib46","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.amjcard.2018.04.006","article-title":"Meta-analysis comparing single versus dual antiplatelet therapy following transcatheter aortic valve implantation","volume":"122","author":"Maes","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib47","first-page":"783","article-title":"Comparison of single versus dual antiplatelet therapy after TAVR: a systematic review and meta-analysis","volume":"92","author":"Raheja","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib48","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2017-000748","article-title":"Optimal antiplatelet strategy after transcatheter aortic valve implantation: a meta-analysis","volume":"5","author":"Ahmad","year":"2018","journal-title":"Open Heart"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib49","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1700456","article-title":"Surgical or transcatheter aortic-valve replacement in intermediate-risk patients","volume":"376","author":"Reardon","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib50","first-page":"389","article-title":"Potential embolization by atherosclerotic debris dislodged from aortic wall during cardiac catheterization: histological and clinical findings in 7,621 patients","volume":"49","author":"Eggebrecht","year":"2000","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib51","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.recesp.2017.06.013","article-title":"Dual versus single antiplatelet regimen with or without anticoagulation in transcatheter aortic valve replacement: indirect comparison and meta-analysis","volume":"71","author":"Verdoia","year":"2018","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib52","first-page":"E177","article-title":"Antithrombotic strategies after transcatheter aortic valve implantation: insights from a network meta-analysis","volume":"96","author":"Kuno","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib53","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/ejcts\/ezz335","article-title":"Comparative efficacy and safety of antithrombotic therapy for transcatheter aortic valve replacement: a systematic review and network meta-analysis","volume":"57","author":"Zhu","year":"2020","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib54","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1911425","article-title":"A\u00a0controlled trial of rivaroxaban after transcatheter aortic-valve replacement","volume":"382","author":"Dangas","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib55","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJMoa1915152","article-title":"Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation","volume":"382","author":"Nijenhuis","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib56","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ahj.2018.03.008","article-title":"Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis: the randomized ATLANTIS trial","volume":"200","author":"Collet","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.athoracsur.2021.09.048_bib57","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ahj.2018.07.006","article-title":"Edoxaban versus standard of care and their effects on clinical outcomes in patients having undergone transcatheter aortic valve implantation in atrial fibrillation-rationale and design of the ENVISAGE-TAVI AF trial","volume":"205","author":"Van Mieghem","year":"2018","journal-title":"Am Heart J"}],"container-title":["The Annals of Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003497521017641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003497521017641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T12:38:14Z","timestamp":1762087094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003497521017641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0003497521017641"],"URL":"https:\/\/doi.org\/10.1016\/j.athoracsur.2021.09.048","relation":{},"ISSN":["0003-4975"],"issn-type":[{"value":"0003-4975","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing Single- and Dual-Antiplatelet Therapies After Transcatheter Aortic Valve Implantation","name":"articletitle","label":"Article Title"},{"value":"The Annals of Thoracic Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.athoracsur.2021.09.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by The Society of Thoracic Surgeons","name":"copyright","label":"Copyright"}]}}